Michael Evan Lidsky, MD
Editorial Board
Dr. Lidsky completed his surgical residency at Duke University followed by subspecialty training in complex general surgical oncology and hepatopancreatobiliary surgery at Memorial Sloan Kettering Cancer Center. He returned to Duke University in 2018 as an Assistant Professor of Surgery within the Division of Surgical Oncology.
Dr. Lidsky’s clinical interests are focused on the care of patients with pre-cancerous and cancerous conditions of the liver, bile ducts, and pancreas, as well as hepatic artery infusion therapy. In addition to Dr. Lidsky’s clinical practice, his research explores functional genomic and molecular mechanisms of tumorigenesis and chemoresistance in primary liver cancer. Specifically, he uses pre-clinical models for cholangiocarcinoma to recapitulate critical events in these tumors, so as to identify mechanisms driving tumor growth, metastasis, and resistance to chemotherapy. Ultimately, this model serves as a vehicle for the discovery of new or more efficacious therapies.